Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Invion ( (AU:IVX) ) just unveiled an announcement.
Invion Limited announced the results of its Extraordinary General Meeting, where all resolutions, including the approval of options issuance to directors and ratification of prior share issues, were carried. This outcome supports Invion’s strategic initiatives and may enhance its operational capabilities and stakeholder confidence.
More about Invion
Invion is a life-science company specializing in the research and development of Photosoft™ technology for treating cancers, atherosclerosis, and infectious diseases. The company holds exclusive rights for this technology in various regions, including Australia, New Zealand, and parts of Asia, and is listed on the ASX.
Average Trading Volume: 100,796
Technical Sentiment Signal: Sell
Current Market Cap: A$7.59M
See more data about IVX stock on TipRanks’ Stock Analysis page.